Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Trial of Mentalization-Based Therapy for Substance Using Mothers of Infants and Toddlers

Not Applicable

Completed

Conditions: Parenting Capacities of Substance Abusing Mothers

Interventions: Behavioral: Mothers and Toddlers Program
Behavioral: Parent Education

First Posted Date: 2010-11-15

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT01240993

Locations: 🇺🇸
The Moms 'n' Kids Program at the APT Foundation, New Haven, Connecticut, United States
🇺🇸
Yale Psychosocial Substance Abuse Research Unit, West Haven, Connecticut, United States

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

Phase 4

Completed

Conditions: Pervasive Development Disorders

Interventions: Drug: extended-release guanfacine
Other: placebo

First Posted Date: 2010-11-10

Last Posted Date: 2020-03-31

Lead Sponsor: Yale University

Target Recruit Count: 62

Registration Number: NCT01238575

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States

and more 2 locations

Tdap Vaccination for Infant Caregivers

Completed

Conditions: Pertussis
Vaccination

Interventions: Other: Survey

First Posted Date: 2010-11-03

Last Posted Date: 2011-07-28

Lead Sponsor: Yale University

Target Recruit Count: 102

Registration Number: NCT01233401

Locations: 🇺🇸
Hospital of St. Raphael, New Haven, Connecticut, United States

Randomized Trial of Parent Training for Young Children With Autism

Not Applicable

Completed

Conditions: Child Development Disorders, Pervasive

Interventions: Behavioral: Parent Training
Other: Psychoeducational Program

First Posted Date: 2010-11-03

Last Posted Date: 2016-04-08

Lead Sponsor: Yale University

Target Recruit Count: 180

Registration Number: NCT01233414

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States

and more 3 locations

A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Dietary Supplement: N-Acetylcysteine
Drug: Placebo

First Posted Date: 2010-11-02

Last Posted Date: 2015-12-01

Lead Sponsor: Yale University

Target Recruit Count: 28

Registration Number: NCT01232790

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention

Phase 2

Completed

Conditions: Reduction in Heavy Drinking in Patients With HIV

Interventions: Drug: Naltrexone
Other: Placebo + Medication Management/Medication Coaching

First Posted Date: 2010-10-22

Last Posted Date: 2019-03-21

Lead Sponsor: Yale University

Target Recruit Count: 51

Registration Number: NCT01227044

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸
VACT Healthcare System, New Haven, Connecticut, United States

Ketamine for Low Mood States in the ER

Phase 1

Completed

Conditions: Suicide Ideation
Depression

Interventions: Drug: ketamine

First Posted Date: 2010-09-27

Last Posted Date: 2020-08-24

Lead Sponsor: Yale University

Target Recruit Count: 14

Registration Number: NCT01209845

Locations: 🇺🇸
Yale New Haven Hospital Emergency Department, New Haven, Connecticut, United States

Efficacy and Tolerability of Riluzole in Treatment Resistant Depression

Phase 2

Completed

Conditions: Depression

Interventions: Drug: placebo
Drug: Riluzole

First Posted Date: 2010-09-17

Last Posted Date: 2020-03-06

Lead Sponsor: Yale University

Target Recruit Count: 104

Registration Number: NCT01204918

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
Yale University, Yale Depression Research Program, New Haven, Connecticut, United States
🇺🇸
Massachussettes General Hospital, Depression Clinical and Research Center, Boston, Massachusetts, United States

Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Formoterol
Other: Placebo

First Posted Date: 2010-09-03

Last Posted Date: 2016-03-29

Lead Sponsor: Yale University

Target Recruit Count: 14

Registration Number: NCT01194479

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Milestones of Adjustment Post-Psychosis

Phase 3

Terminated

Conditions: Quality of Life
Adjustment, Psychological
Signs and Symptoms
Schizophrenia
Medication Adherence

Interventions: Behavioral: Training in all modules including MAPP Recovery Model
Behavioral: Training in all modules except MAPP Recovery Model

First Posted Date: 2010-09-01

Last Posted Date: 2016-09-08

Lead Sponsor: Yale University

Target Recruit Count: 110

Registration Number: NCT01192594

Locations: 🇺🇸
The Connection Inc, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy